PUBLISHER: The Business Research Company | PRODUCT CODE: 1760726
PUBLISHER: The Business Research Company | PRODUCT CODE: 1760726
Tissue engineering for wound care is a specialized area that focuses on enhancing the natural repair and regeneration of damaged tissue by combining biological components, such as cells and supportive materials. The goal is to create an environment conducive to healing, promoting the growth of new tissue.
Key materials used in tissue engineering for wound care include scaffolds, tissue grafts, and other supportive materials. A scaffold is a three-dimensional structure that provides physical support to cells, allowing them to attach, proliferate, and differentiate to form new tissue. Scaffolds are used in the treatment of both chronic and acute wounds, and they are applied in skin regeneration, bone and cartilage regeneration, soft tissue repair, and organ regeneration. These products are utilized by various end-users, such as hospitals, specialty centers and clinics, and ambulatory surgical centers.
The tissue engineering for wound care market research report is one of a series of new reports from The Business Research Company that provides tissue engineering for wound care market statistics, including tissue engineering for wound care industry global market size, regional shares, competitors with a tissue engineering for wound care market share, detailed tissue engineering for wound care market segments, market trends and opportunities, and any further data you may need to thrive in the tissue engineering for wound care industry. This tissue engineering for wound care market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The tissue engineering for wound care market size has grown rapidly in recent years. It will grow from $6.08 billion in 2024 to $6.99 billion in 2025 at a compound annual growth rate (CAGR) of 15.1%. The growth during the historic period can be attributed to factors such as the rising prevalence of chronic wounds, an aging population, a higher incidence of traumatic injuries from accidents and burns, supportive government initiatives and funding for wound care research, and increased healthcare expenditure.
The tissue engineering for wound care market size is expected to see rapid growth in the next few years. It will grow to $12.15 billion in 2029 at a compound annual growth rate (CAGR) of 14.8%. The growth during the forecast period can be attributed to factors such as rising awareness of wound care management among patients, an increasing number of surgeries and surgery-related wounds, a high incidence of diabetes and related complications, a rise in the number of skin grafts and regenerative treatments, and more research and development activities. Key trends during this period include advancements in tissue engineering technologies, the availability of advanced biomaterials for tissue regeneration, innovations in 3D bioprinting for wound healing, greater adoption of biologically-based wound care products, and collaborations between academic institutions and the industry.
The rising prevalence of musculoskeletal disorders is expected to drive the growth of the tissue engineering for wound care market in the coming years. Musculoskeletal disorders, which affect muscles, bones, joints, tendons, or ligaments, lead to pain, stiffness, and limited movement. These conditions are becoming more common due to increasingly sedentary lifestyles, where prolonged sitting and reduced physical activity contribute to muscle weakening and joint stress, resulting in long-term health issues. Tissue engineering for wound care plays a crucial role in addressing musculoskeletal disorders by promoting the regeneration of damaged tissues, helping restore function and structure in areas where natural healing is insufficient. For example, a report by the Office for Health Improvement and Disparities in March 2023 revealed that 17.6% of individuals aged 16 and over in the UK self-reported a long-term musculoskeletal condition in 2022, up from 17.0% in 2021. As a result, the increasing prevalence of musculoskeletal disorders is expected to drive the growth of the tissue engineering for wound care market.
Advancements in intraoperative 3D printing are revolutionizing personalized wound care, with companies in the tissue engineering for wound care market focusing on developing innovative solutions. Intraoperative 3D printers are advanced devices used during surgical procedures to create customized implants, models, or tools in real-time, improving precision and enabling patient-specific treatments. For example, in September 2024, Tides Medical, a US-based biotechnology company, launched the APLICOR 3D, a personalized wound care intraoperative 3D printer. This technology transforms wound care by using the patient's own tissue, artificial intelligence, and 3D printing to create personalized skin grafts directly at the treatment site. The process is streamlined, simplifying supply chain logistics, reducing inventory needs, and lessening physician workload. After scanning the wound with a specialized tablet to determine the precise size, depth, and tissue volume, the 3D file is sent to the printer. The printer then constructs the graft using bio-ink made from processed fat, allowing effective wound closure in under an hour.
In March 2022, Convatec Group Plc, a UK-based company specializing in medical products and technologies, acquired Triad Life Sciences Inc. for $450 million. This acquisition allows Convatec to expand its advanced wound care portfolio and enhance its position in the regenerative medicine market. The move reinforces Convatec's leadership in regenerative wound care solutions and supports the development of advanced biologically derived therapies. Triad Life Sciences Inc. is a US-based company, known for providing tissue engineering solutions for wound care.
Major players in the tissue engineering for wound care market are Zimmer Biomet Holdings Inc., Smith & Nephew plc, ConvaTec Group Plc, MTF Biologics Wound Care, StemSys Technologies Inc., MiMedx Group Inc., LIFENET HEALTH INC., Vericel, BioTissue Inc., Kerecis LLC, Aroa Biosurgery Ltd., Avita Medical, PolyNovo Limited, Tissue Regenix Group PLC, CollPlant Biotechnologies Ltd., BioStem Technologies Inc., InGeneron Inc., Applied Tissue Technologies LLC, Conexeu Sciences Inc., and WTG Biotech.
North America was the largest region in the tissue engineering for wound care market in 2024. The regions covered in tissue engineering for wound care report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the tissue engineering for wound care market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The tissue engineering for wound care market consists of revenues earned by entities by providing services such as cell culture and expansion services, biomaterial research and development, and wound healing assessment and analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The tissue engineering for wound care market also includes sales of engineered skin substitutes, hydrogel dressings, bioactive wound dressings, and 3D bioprinted tissues. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Tissue Engineering For Wound Care Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on tissue engineering for wound care market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for tissue engineering for wound care ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The tissue engineering for wound care market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.